Work

Expanding the scope of the withdrawal syndrome: Anhedonia as a core nicotine withdrawal symptom.

Year: 2025

Type: article

Abstract: < .001) post-TQD. These effects remained even after controlling for other withdrawal symptoms and individual characteristics. Gold standard smoking pharmacotherapies had comparable statistical effects on anhedonia's trajectory and association with abstinence during treatment. The results replicate and extend previous research supporting anhedonia as a motivationally significant symptom of nicotine withdrawal. The results suggest anhedonia not only conforms to features of a tobacco withdrawal symptom but is associated with difficulty stopping smoking. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Source: Journal of Psychopathology and Clinical Science

DOI: 10.1037/abn0000981